CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 33 filers reported holding CHEMBIO DIAGNOSTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $4,925,000 | +8.9% | 808,673 | -0.7% | 0.30% | +8.2% |
| Q1 2019 | $4,521,000 | -5.0% | 814,617 | -3.1% | 0.28% | -3.4% |
| Q4 2018 | $4,758,000 | -27.6% | 840,601 | +34.2% | 0.29% | -4.9% |
| Q3 2018 | $6,575,000 | -8.3% | 626,182 | -3.0% | 0.31% | -8.9% |
| Q2 2018 | $7,167,000 | +70.8% | 645,718 | +23.1% | 0.34% | +63.6% |
| Q1 2018 | $4,195,000 | – | 524,388 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Penbrook Management LLC | 344,060 | $1,634,000 | 1.26% |
| Union Square Park Capital Management, LLC | 400,000 | $1,900,000 | 0.76% |
| P.A.W. CAPITAL CORP | 100,000 | $475,000 | 0.42% |
| PRECEPT MANAGEMENT LLC | 150,000 | $713,000 | 0.29% |
| Newbridge Financial Services Group, Inc. | 73,500 | $349,000 | 0.29% |
| SANDERS MORRIS HARRIS LLC | 183,584 | $990,000 | 0.22% |
| FRIESS ASSOCIATES LLC | 555,000 | $2,636,000 | 0.19% |
| PERRITT CAPITAL MANAGEMENT INC | 30,651 | $146,000 | 0.09% |
| Ikarian Capital, LLC | 219,109 | $1,041,000 | 0.05% |
| SEGALL BRYANT & HAMILL, LLC | 705,823 | $3,352,000 | 0.04% |